Section 32 is a venture capital fund investing at the frontiers of technology and healthcare. Founded by Bill Maris, the team has vast experience building iconic companies.
Our goal is to improve the human condition by accelerating the discovery, development and distribution of important technologies and life saving medicines.
We invest across the entirety of technology and healthcare. This includes software, cybersecurity, advanced communications and computation, space, climate change related technologies, machine learning, artificial intelligence, biotechnology, therapeutics, advanced diagnostics, precision medicine, genomics and more.